518 related articles for article (PubMed ID: 18328600)
1. Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Cwik M; Walkup J; Weis S
Neurochem Int; 2008 May; 52(6):1297-303. PubMed ID: 18328600
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Dulay JR; Weis S
Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
[TBL] [Abstract][Full Text] [Related]
3. Kynurenine pathway in psychosis: evidence of increased tryptophan degradation.
Barry S; Clarke G; Scully P; Dinan TG
J Psychopharmacol; 2009 May; 23(3):287-94. PubMed ID: 18562404
[TBL] [Abstract][Full Text] [Related]
4. Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia.
Miller CL; Llenos IC; Dulay JR; Barillo MM; Yolken RH; Weis S
Neurobiol Dis; 2004 Apr; 15(3):618-29. PubMed ID: 15056470
[TBL] [Abstract][Full Text] [Related]
5. Tryptophan breakdown pathway in bipolar mania.
Myint AM; Kim YK; Verkerk R; Park SH; Scharpé S; Steinbusch HW; Leonard BE
J Affect Disord; 2007 Sep; 102(1-3):65-72. PubMed ID: 17270276
[TBL] [Abstract][Full Text] [Related]
6. Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats.
Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Grant R
FEBS J; 2011 Nov; 278(22):4425-34. PubMed ID: 22032336
[TBL] [Abstract][Full Text] [Related]
7. The high-affinity niacin receptor HM74A is decreased in the anterior cingulate cortex of individuals with schizophrenia.
Miller CL; Dulay JR
Brain Res Bull; 2008 Sep; 77(1):33-41. PubMed ID: 18639743
[TBL] [Abstract][Full Text] [Related]
8. [Enzymes of the kynurenine pathway].
Tankiewicz A; Pawlak D; Buczko W
Postepy Hig Med Dosw; 2001; 55(5):715-31. PubMed ID: 11795205
[TBL] [Abstract][Full Text] [Related]
9. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia.
Webster MJ; O'Grady J; Kleinman JE; Weickert CS
Neuroscience; 2005; 133(2):453-61. PubMed ID: 15885920
[TBL] [Abstract][Full Text] [Related]
10. Tryptophan metabolism along the kynurenine pathway in diet-induced and genetic hypercholesterolemic rabbits.
Allegri G; Ragazzi E; Costa CV; Caparrotta L; Biasiolo M; Comai S; Bertazzo A
Clin Chim Acta; 2004 Dec; 350(1-2):41-9. PubMed ID: 15530458
[TBL] [Abstract][Full Text] [Related]
11. Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder.
Thomas EA; Dean B; Scarr E; Copolov D; Sutcliffe JG
Mol Psychiatry; 2003 Feb; 8(2):167-75. PubMed ID: 12610649
[TBL] [Abstract][Full Text] [Related]
12. Altered kynurenine metabolism correlates with infarct volume in stroke.
Darlington LG; Mackay GM; Forrest CM; Stoy N; George C; Stone TW
Eur J Neurosci; 2007 Oct; 26(8):2211-21. PubMed ID: 17892481
[TBL] [Abstract][Full Text] [Related]
13. The kynurenine pathway in schizophrenia and bipolar disorder.
Erhardt S; Schwieler L; Imbeault S; Engberg G
Neuropharmacology; 2017 Jan; 112(Pt B):297-306. PubMed ID: 27245499
[TBL] [Abstract][Full Text] [Related]
14. DNA fragmentation decreased in schizophrenia but not bipolar disorder.
Benes FM; Walsh J; Bhattacharyya S; Sheth A; Berretta S
Arch Gen Psychiatry; 2003 Apr; 60(4):359-64. PubMed ID: 12695312
[TBL] [Abstract][Full Text] [Related]
15. M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders.
Zavitsanou K; Katsifis A; Yu Y; Huang XF
Brain Res Bull; 2005 May; 65(5):397-403. PubMed ID: 15833594
[TBL] [Abstract][Full Text] [Related]
16. Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression.
Laugeray A; Launay JM; Callebert J; Surget A; Belzung C; Barone PR
Behav Brain Res; 2010 Jun; 210(1):84-91. PubMed ID: 20153778
[TBL] [Abstract][Full Text] [Related]
17. Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients.
Myint AM; Schwarz MJ; Verkerk R; Mueller HH; Zach J; Scharpé S; Steinbusch HW; Leonard BE; Kim YK
Brain Behav Immun; 2011 Nov; 25(8):1576-81. PubMed ID: 21620952
[TBL] [Abstract][Full Text] [Related]
18. Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery.
Forrest CM; Mackay GM; Oxford L; Millar K; Darlington LG; Higgins MJ; Stone TW
J Neurochem; 2011 Oct; 119(1):136-52. PubMed ID: 21819405
[TBL] [Abstract][Full Text] [Related]
19. Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine.
Johansson AS; Owe-Larsson B; Asp L; Kocki T; Adler M; Hetta J; Gardner R; Lundkvist GB; Urbanska EM; Karlsson H
J Psychiatr Res; 2013 Nov; 47(11):1815-23. PubMed ID: 24012176
[TBL] [Abstract][Full Text] [Related]
20. Tryptophan metabolites interfere with the Ehrlich reaction used for the measurement of kynurenine.
Alegre E; López AS; González A
Anal Biochem; 2005 Apr; 339(1):188-9. PubMed ID: 15766729
[No Abstract] [Full Text] [Related]
[Next] [New Search]
